Determinants of CRISPR Cas12a nuclease activation by DNA and RNA targets
Nucleic Acids Research · 08.05.2024 · 52 (8) · 4502-4522
DOI: 10.1093/nar/gkae152 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 13.03.2024. Verfasst von Eric A Nalefski und 5 weiteren Autor:innen. Beteiligte Einrichtung: Global Health Labs, Inc, Bellevue, WA 98007, USA. Hauptthemen laut MEDLINE: CRISPR-Associated Proteins, CRISPR-Cas Systems, DNA, Single-Stranded, Endodeoxyribonucleases. Die Arbeit wurde bisher 64-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Global Health Labs, Inc.
Abstract (Originalsprache)
The RNA-guided CRISPR-associated (Cas) enzyme Cas12a cleaves specific double-stranded (ds-) or single-stranded (ss-) DNA targets (in cis), unleashing non-specific ssDNA cleavage (in trans). Though this trans-activity is widely coopted for diagnostics, little is known about target determinants promoting optimal enzyme performance. Using quantitative kinetics, we show formation of activated nuclease proceeds via two steps whereby rapid binding of Cas12a ribonucleoprotein to target is followed by a slower allosteric transition. Activation does not require a canonical protospacer-adjacent motif (PAM), nor is utilization of such PAMs predictive of high trans-activity. We identify several target determinants that can profoundly impact activation times, including bases within the PAM (for ds- but not ssDNA targets) and sequences within and outside those complementary to the spacer, DNA topology, target length, presence of non-specific DNA, and ribose backbone itself, uncovering previously uncharacterized cleavage of and activation by RNA targets. The results provide insight into the mechanism of Cas12a activation, with direct implications on the role of Cas12a in bacterial immunity and for Cas-based diagnostics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Global Health Labs, Inc, Bellevue, WA 98007, USA.
ORCID-Profile: Eric A Nalefski, Damian Madan
Förderung
- Global Health Labs, Inc
Zitieren
APA
Nalefski, E. A., Kooistra, R. M., Parikh, I., Hedley, S., Rajaraman, K., & Madan, D. (2024). Determinants of CRISPR Cas12a nuclease activation by DNA and RNA targets. Nucleic Acids Research, 52(8), 4502-4522. https://doi.org/10.1093/nar/gkae152
Vancouver
Nalefski EA, Kooistra RM, Parikh I, Hedley S, Rajaraman K, Madan D. Determinants of CRISPR Cas12a nuclease activation by DNA and RNA targets. Nucleic Acids Research. 2024;52(8):4502-4522. doi:10.1093/nar/gkae152
BibTeX
@article{Nalefski2024,
author = {Nalefski, Eric A and Kooistra, Remy M and Parikh, Ishira and Hedley, Samantha and Rajaraman, Karunya and Madan, Damian},
title = {Determinants of CRISPR Cas12a nuclease activation by DNA and RNA targets},
journal = {Nucleic Acids Research},
year = {2024},
volume = {52},
number = {8},
pages = {4502--4522},
doi = {10.1093/nar/gkae152}
}
EUVIMED